These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37047569)

  • 1. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
    Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haptoglobin is an independent marker for disease severity and risk for metabolic complications in hidradenitis suppurativa: A prospective study.
    Abu Rached N; Gambichler T; Ocker L; Skrygan M; Seifert C; Scheel CH; Stockfleth E; Bechara FG
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):205-213. PubMed ID: 37669834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
    Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
    Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
    Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
    Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
    Hayama K; Fujita H; Hashimoto T; Terui T;
    J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015.
    Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
    Dermatology; 2024; 240(4):553-564. PubMed ID: 38621365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria.
    Anaba EL; Bouazzi D; Ajayi PV; Aro OO; Boer J; Jemec GBE
    Dermatology; 2023; 239(5):832-835. PubMed ID: 37343527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
    Balcere A; Upeniece I; Snipe K; Jezupovs A
    Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.
    Almuhanna N; Tobe SW; Alhusayen R
    Dermatology; 2023; 239(6):912-918. PubMed ID: 37487485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial fat thickness is ıncreased and associated with disease severity in hidradenitis suppurativa.
    Alatas ET; Biteker M; Alatas OD
    Arch Dermatol Res; 2020 Sep; 312(7):467-472. PubMed ID: 31894390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey.
    Yüksel M; Basım P
    J Cutan Med Surg; 2020; 24(1):55-59. PubMed ID: 31698918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan.
    Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
    J Dermatol; 2019 Oct; 46(10):867-873. PubMed ID: 31389066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.